A56V (p.Ala56Val) variant of DTX1 (E3 ubiquitin-protein ligase DTX1)

A56V (p.Ala56Val) in DTX1 (E3 ubiquitin-protein ligase DTX1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.51 / 1. The record also includes population frequency data and structural context.

A56V (p.Ala56Val) variant details